Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Pediatrics, Asan Medical Center, Seoul, Korea.
J Korean Med Sci. 2021 Nov 15;36(44):e283. doi: 10.3346/jkms.2021.36.e283.
Despite advancements in heart transplantation for pediatric patients in Korea, the waiting list mortality has not been reported. Therefore, we investigated the waiting list mortality rate and factors associated with patient mortality.
We reviewed the medical records of pediatric patients who were registered for heart transplantation at three major hospitals in Korea from January 2000 to January 2020. All patients who died while waiting for heart transplantation were investigated, and we identified the waiting list mortality rate, causes of mortality and median survival periods depending on the variable risk factors.
A total of 145 patients received heart transplantations at the three institutions we surveyed, and the waiting list mortality rate was 26%. The most common underlying diseases were cardiomyopathy (66.7%) and congenital heart disease (30.3%). The leading causes that contributed to death were heart failure (36.3%), multi-organ failure (27.2%), and complications associated with extracorporeal membrane oxygenation (ECMO) (25.7%). The median survival period was 63 days. ECMO was applied in 30 patients. The different waiting list mortality percentages according to age, cardiac diagnosis, use of ECMO, and initial Korean Network of Organ Sharing (KONOS) level were determined using univariate analysis, but age was the only significant factor associated with waiting list mortality based on a multivariate analysis.
The waiting list mortality of pediatric heart transplantation candidates was confirmed to be considerably high, and age, underlying disease, the application of ECMO, and the initial KONOS level were the factors that influenced the survival period.
尽管韩国在儿科患者心脏移植方面取得了进步,但尚未报告候补者的死亡率。因此,我们调查了候补者的死亡率以及与患者死亡相关的因素。
我们回顾了 2000 年 1 月至 2020 年 1 月在韩国三所主要医院登记的儿科患者的病历。对所有在等待心脏移植期间死亡的患者进行了调查,并根据可变风险因素确定了候补者死亡率、死亡原因和中位生存时间。
在我们调查的三所机构中,共有 145 名患者接受了心脏移植,候补者死亡率为 26%。最常见的基础疾病是心肌病(66.7%)和先天性心脏病(30.3%)。导致死亡的主要原因是心力衰竭(36.3%)、多器官衰竭(27.2%)和与体外膜肺氧合(ECMO)相关的并发症(25.7%)。中位生存时间为 63 天。30 名患者接受了 ECMO 治疗。使用单变量分析确定了根据年龄、心脏诊断、使用 ECMO 和初始韩国器官共享网络(KONOS)水平的不同候补者死亡率百分比,但基于多变量分析,年龄是唯一与候补者死亡率相关的显著因素。
儿科心脏移植候选者的候补者死亡率被证实相当高,年龄、基础疾病、ECMO 的应用以及初始 KONOS 水平是影响生存时间的因素。